Tuesday, Oppenheimer upgraded Avalo Therapeutics Inc AVTX, noting that its AVTX-009 is a promising drug candidate and looks forward to a Phase 2 topline…
Monday, Roche Holdings AG RHHBY announced topline data from Phase 3 STARGLO study of Columvi (glofitamab) in combination with gemcitabine plus oxaliplatin (GemOx) versus…
MADRID (Reuters) – Spanish drug maker Grifols, battling a plunge in its share price this year, plans to add independent…
U.S. District Judge Roy Altman ruled that the drugmaker Eli Lilly And Co LLY cannot rely on state law to stop a compounding pharmacy, RXCompoundStore.com,…
Friday, Agenus Inc AGEN released updated results from its Phase 1 clinical trial of botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic…
The U.S. Justice Department has leveled allegations against Regeneron Pharmaceuticals REGN, accusing the company of manipulating Medicare’s drug-pricing system for its macular…
By Nate Raymond and Dan Whitcomb BOSTON (Reuters) -The U.S. Justice Department on Wednesday accused Regeneron (NASDAQ:) Pharmaceuticals of manipulating…
A recent federal report indicates that the number of positive drug tests among commercial truck drivers declined by more than…
On Sunday, Alnylam Pharmaceuticals Inc. ALNY presented results from the KARDIA-2 Phase 2 study, which evaluated the efficacy and safety of a…
Saturday, Bristol Myers Squibb & Co BMY released interim long-term safety, tolerability, and metabolic outcomes data from its Phase 3 EMERGENT program…